Aim: In our study an attempt has been made to find the prevalence of genetic thrombophilia in recurrent pregnancy loss (RPL). Methods: Methylene tetrahydrofolate reductase C677 (MTHFR C677T) and factor V Leiden (FVL) were investigated in 84 Rajput women with two or more pregnancy losses and in 80 age- and ethnicity-matched healthy controls. Restriction digestions of polymerase chain reaction product with HinfI and Mnl I were used for MTHFR C677T and FVL polymorphism detection, respectively. Results:MTHFR C677T mutation was found in 9/84 patients (10.71%) and 2/80 controls (2.5%), yielding an odds ratio (OR) for RPL related to MTHFR C677T of 4.68 (95% confidence interval [CI] = 0.98-22.37; p = 0.03). FVL was found in 4/84 patients (4.76%) and none among the controls, yielding a modified OR for RPL related to FVL of 9.00 (95% CI = 0.48-169.9; p = 0.05). Both, MTHFR C677T and FVL were not found to be significantly more prevalent in patients than controls as a whole. However, MTHFR C677T showed significant association with early pregnancy loss (OR = 6.3; 95% CI = 1.22-32.85; p-value = 0.03; Bonferroni-corrected p-value = 0.04). Conclusions: Our study supports the association between MTHFR C677T and patients with early RPL among north Indian Rajputs and strengthens the notion that thrombophilia plays a role in this clinical entity.
Get full access to this article
View all access options for this article.
References
1.
AksoyM, TekI, KarabulutHet al.2005. The role of thrombophilia related to factor V Leiden and factor II G20210A mutations in recurrent abortions. J Pak Med Assoc, 55:104-108.
2.
AyresKL, OverallADJ. 1999. Allowing for within-subpopulation inbreeding in forensic match probabilities. Forensic Sci Int, 103:207-216
3.
BalaschJ, ReverterJC, FábreguesFet al.1997. First-trimester repeated abortion is not associated with activated protein C resistance. Hum Reprod, 12:1094-1097.
4.
BeauchampNJ, DalyME, HamptonKKet al.1994. High prevalence Prothrombin G20210A was reported to be more common of a mutation in the factor V gene within the UK population: relationship to activated protein C resistance and familial thrombosis. Br J Haematol, 88:219-222.
5.
BiswasA, ChoudhryP, MittalAet al.2008. Recurrent abortions in Asian Indians: no role of factor V Leiden Hong Kong/Cambridge mutation and MTHFR polymorphism. Clin Appl Thromb Hemost, 14:102-104.
6.
BrennerB, BlumenfeldZ. 1997. Thrombophilia and fetal loss. Blood Rev, 11:72-79
7.
BrennerB, MandelH, LanirNet al.1997. Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol, 97:551-554.
8.
BrennerB, SarigG, WeinerZet al.1999. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost, 82:6-9.
9.
CarpH, SalomenO, SeidmanDet al.2002. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod, 17:1633-1637.
10.
CoutoE, BariniR, ZaccariaRet al.2005. Association of anticardiolipin antibody and C677T in methylenetetrahydrofolate reductase mutation in women with recurrent spontaneous abortions: a new path to thrombophilia?Sao Paulo Med J, 123:15-20.
11.
Dizon-TownsonDS, KinneyS, BranchDW, WardK. 1997. The factor V Leiden mutation is not a common cause of recurrent miscarriage. J Reprod Immunol, 34:217-223
12.
FokaZJ, LambropoulosAF, SaravelosHet al.2000. Factor V Leiden and factor II G20210A mutations, but not methylenetetrahydrofolate reductase C677 are associated with recurrent miscarriage. Hum Reprod, 1:458-462.
13.
FrosstP, BlomHJ, MilosRet al.1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 10:111-113.
14.
GrandoneE, MargaglioneM, ColaizzoDet al.1997. Factor V leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemostasis, 77:822-824.
15.
HashimotoK, ShizusawaY, ShimoyaKet al.1999. The factor V Leiden mutation in Japanese couples with recurrent spontaneous abortion. Hum Reprod, 14:1872-1874.
16.
JaffeR. 1993. Investigation of abnormal first-trimester gestations by colour Doppler imaging. J Clin Ultrasound, 21:521-526
17.
KobashiG, KatoEH, MorikawaMet al.2005. MTHFR C677T polymorphism and factor V Leiden mutation are not associated with recurrent spontaneous abortion of unexplained etiology in Japanese women. Semin Thromb Hemost, 31:266-271.
18.
KumarKSD, GovindaiahV, NaushadSEet al.2003. Plasma homocysteine levels correlated to interactions between folate status and methylene tetrahydrofolate reductase gene mutation in women with unexplained recurrent pregnancy loss. J Obstet Gynecol, 23:55-58.
19.
KuttehWH, ParkVM, DeitcherSR. 1999. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril, 71:1048-1054
20.
LissakA, SharonA, FruchterOet al.1999. Polymorphism for mutation of cytosine to thymine at location 677 in the methylenetetrahydrofolate reductase gene is associated with recurrent early fetal loss. Am J Obstet Gynecol, 181:126-130.
21.
MalhotraP, DasR, AhiuwaliaJet al.2006. Factor V Leiden mutation is not associated with recurrent pregnancy loss in north Indians (abstract book)Proceedings of the International Symposium on Human Genomics and Public Health and the XXXII Annual Conference of the Indian Society of Human Genetics, Kolkata, India, 106.
22.
MartinelliI, TaioliE, CetinIet al.2000. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med, 343:1015-1018.
23.
MillerSA, DykesDP, PoleskyHF. 1988. A simple salting out procedure of extracting DNA from human nucleated cells. Nucleic Acid Res, 16:1215-1217.
24.
MtiraouiN, BorgiL, HizemSet al.2005. Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol, 119:164-170.
25.
NelenWL, BlomHJ, ThomasCMet al.1998. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr, 128:1336-1341.
26.
PrestonFE, RosendaalFR, WalkerIDet al.1996. Increased fetal loss in women with heritable thrombophilia. Lancet, 348:913-916.
27.
QuereI, BelletH, HoffetMet al.1998. A women with five consecutive fetal deaths: case report and retrospective analysis of hyperhomocystaenemia prevalence in 100 consecutive women with recurrent miscarriages. Fertil Steril, 69:152-154.
28.
RaiR, BackosM, ElgaddalSet al.2002. Factor V Leiden and recurrent miscarriage—prospective outcome of untreated pregnancies. Hum Reprod, 17:442-445.
29.
ReganL. 1998. Overview of recurrent miscarriage. Gynaecol Forum, 3:3-7
30.
ReyE, KahnSR, DavidMet al.2003. Thrombophilic disorders and fetal loss: a meta analysis. Lancet, 361:901-908.
31.
RidkerPM, MiletichJP, BuringJEet al.1998. Factor V leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med, 128:1000-1003.
32.
RobertsonL, WuO, LanghornePet al.2006. Thrombophilia in pregnancy: a systematic review. Br J Haematol, 132:171-196.
33.
ShoemakerJ, PainterI, WeirBS. 1998. A Bayesian characterization of Hardy-Weinberg disequilibrium. Genetics, 149:2079-2088
34.
SoleX, GuinoE, VallsJ, IniestaR, MorenoV. 2006. SNPStats: a web tool for the analysis of association studies. Bioinformatics, 22:1928-1929
35.
StirlingY, WoolfL, NorthWRet al.1984. Haemostasis in normal pregnancy. Thromb Haemostasis, 52:176-182.
36.
WolfCE, HaubeltH, PauerHUet al.2003. Recurrent pregnancy loss and its relation to FV Leiden, FII G20210A and polymorphisms of plasminogen activator and plasminogen activator inhibitor. Pathophysiol Haemost Thromb, 33:134-137.
37.
WramsbyML, Sten-Linder, BremmeKS. 2000. Primary habitual abortions are associated with high frequency of factor V leiden mutation. Fertil Steril, 74:987-991
38.
ZouGY, DonnerA. 2006. The merits of testing Hardy-Weinberg equilibrium in the analysis of unmatched case-control data: a cautionary note. Ann Hum Genet, 70:923-933
